Settled, neither admitted nor denied US NYSE

Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives

Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand.

CASE PROFILE & BENCHMARKS
  • Target Issuer: Bristol-Myers Squibb Company (US).
  • Fraud Period: January 1, 2004 to December 31, 2006.
  • Reported Overstatement: $2.0B.
  • Total Fines & Penalties: $150.0M.
  • Maximum Incarceration: No prison sentence.
  • Independent Auditor: PricewaterhouseCoopers LLP.
  • Primary Schemes: channel stuffing.
  • Enforcement Status: SETTLED (neither admit nor deny).
OVERSTATEMENT $2.0B USD reported
TOTAL PENALTIES $150.0M Civil & disgorgement
PRISON TIME None No prison sentence
FIRST ACTION September 20, 2006 Initial proceeding
DETECTION METHOD Regulatory Enforcement & Forensic Audit Discovery source
PRIMARY REGULATOR U.S. Securities and Exchange Commission US

FORENSIC ACCOUNTING AUTOPSY & MECHANICS

HOW IT WAS DONE
Forensic Aspect Regulatory Record & Ledger Mechanics
Accounting Mechanics Without admitting or denying the findings, the respondents consented to orders establishing that The company manipulated its accounting records by executing schemes under channel-stuffing. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.
Evidentiary Finding Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand.
Mechanism Definition Shipping excessive quantities of inventory to distributors or resellers ahead of real demand to prematurely recognize revenue.
Affected Accounts Accounts Receivable (Asset) • Revenue (Income Statement) • Cost of Goods Sold (Income Statement) • Inventory (Asset)
Issuer Corporate Context Pharmaceutical manufacturer that stuffed wholesale distribution channels with $2B in excess inventory using financial incentives.
Independent Auditor PricewaterhouseCoopers LLP : Big Four accounting network sanctioned for audit failures in Satyam, Colonial Bank, Evergrande, and independence violations.
Primary Discovery Method Regulatory Enforcement & Forensic Audit

ILLUSTRATIVE GENERAL LEDGER MECHANICS (CHANNEL STUFFING)

IMPROPER VS. GAAP/IFRS TREATMENT
Improper Booked Entry Proper GAAP / IFRS Treatment Accounting Distortion & Mechanism
DR: Accounts Receivable: $10,000,000
CR: Sales Revenue: $10,000,000
DR: Finished Goods Inventory (remains on balance sheet): $6,000,000
CR: No revenue or AR recognized until legitimate delivery and demand criteria met
Issuer books large sales at quarter end by inducing distributors to take unneeded stock under deep discounts, secret return privileges, or extended payment terms.

FINANCIAL STATEMENT & RATIO DISTORTIONS

QUANTITATIVE SCREENING SIGNALS
Financial Metric / Ratio Distortion Direction Forensic Explanation
Days Sales Outstanding (DSO) Increases sharply Receivables surge because distributors cannot or do not pay for inventory they cannot sell.
Receivables to Revenue Ratio Increases Accounts receivable expands far faster than cash collections.
Gross Margin Unstable or declines next period Concessions, return allowances, or steep price cuts eventually compress margins.
Taxonomy Applicable Scheme Classifications
Correlated Schemes

CHARGED RESPONDENTS & OUTCOMES

1 NAMED PARTIES
Respondent Role Disposition & Judicial Outcome Prison Civil Penalty O&D Bar
Bristol-Myers Squibb Company ISSUER Enforcement order and financial sanctions imposed. None $150.0M No

RED FLAGS OBSERVED PRIOR TO DISCOVERY

1 EARLY WARNING INDICATORS
Red Flag Indicator Period Observed Observed Forensic Anomaly Diagnostic View
CASH FLOW TO NET INCOME DIVERGENCE 2004 Operating cash flow severely diverged from reported earnings Inspect Metric →

ENFORCEMENT ACTIONS & PRIMARY DOCKETS

PRIMARY SOURCE CITATIONS
Filing Date Type & Docket ID Enforcement Order & Regulatory Findings Disposition Primary Record
September 20, 2006
aaer
ENF-2004-bristol-myers-squibb
Enforcement Action: Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives
Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand.
Securities & Corporate Law Compliance
Source: U.S. Securities and Exchange Commission: Accounting and Auditing Enforcement Releases (AAER) • Official Jurisdiction: US
neither admit nor deny Docket Record ↗

TIMELINE OF EVENTS

2 CHRONOLOGICAL MILESTONES
Date Event Category Chronological Forensic Milestone
June 1, 2004 MISSTATEMENT Material accounting irregularities commenced.
September 20, 2006 ENFORCEMENT Regulators commenced formal proceedings.